These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22264843)

  • 1. Perceptions of Canadian primary care physicians towards cardiovascular risk assessment and lipid management.
    Gupta M; Singh N; Tsigoulis M; Kajil M; Hirjikaka S; Quan A; Teoh H; Verma S
    Can J Cardiol; 2012; 28(1):14-9. PubMed ID: 22264843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists.
    Parsi KK; Brezinski EA; Lin TC; Li CS; Armstrong AW
    J Am Acad Dermatol; 2012 Sep; 67(3):357-62. PubMed ID: 22079041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study].
    Barrios V; Gómez-Huelgas R; Rodríguez R; de Pablos-Velasco P
    Rev Esp Cardiol; 2008 Nov; 61(11):1159-67. PubMed ID: 19000491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How can we know what doctors know?
    Stone JA
    Can J Cardiol; 2012; 28(1):11-3. PubMed ID: 22264842
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey.
    Smith SC; Haslam D
    Curr Med Res Opin; 2007 Jan; 23(1):29-47. PubMed ID: 17261236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of C-reactive protein measurement in risk stratification during primary cardiovascular disease prevention.
    Bard RL; Rubenfire M; Eagle K; Clarke NS; Brook RD
    Am J Cardiol; 2005 Jun; 95(11):1378-9. PubMed ID: 15904650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk.
    Billups KL; Miner MM; Wierzbicki AS; Jackson G
    Int J Clin Pract; 2011 Feb; 65(2):134-47. PubMed ID: 21199197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
    Koenig W; Löwel H; Baumert J; Meisinger C
    Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH; Newby LK
    Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians.
    Windgassen EB; Funtowicz L; Lunsford TN; Harris LA; Mulvagh SL
    Postgrad Med; 2011 Jan; 123(1):114-9. PubMed ID: 21293091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the change in the Framingham Risk Score calculator between the 2006 and 2009 Canadian lipid guidelines.
    Armstrong DW; Brouillard D; Matangi MF
    Can J Cardiol; 2011; 27(2):167-70. PubMed ID: 21459264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.
    Oliveira AC; Oliveira AM; Almeida MS; Silva AM; Adan L; Ladeia AM
    J Pediatr; 2008 Mar; 152(3):337-42. PubMed ID: 18280837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT)].
    Silber S; Jarre F; Pittrow D; Klotsche J; Pieper L; Zeiher AM; Wittchen HU;
    Med Klin (Munich); 2008 Sep; 103(9):638-45. PubMed ID: 18813887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinic.
    Pirro M; Del Giorno R; Lupattelli G; Mannarino MR; Roscini AR; Covelli D; Schillaci G; Pasqualini L; Bagaglia F; Siepi D; Mannarino E
    Eur J Intern Med; 2011 Aug; 22(4):412-7. PubMed ID: 21767761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein: a new risk assessment tool for cardiovascular disease.
    Clearfield MB
    J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Framing cardiovascular disease event risk prediction.
    Stone JA
    Can J Cardiol; 2011; 27(2):171-3. PubMed ID: 21459265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.